Inventor
JONCZYK ALFRED
DE45 patents
⚠️ This page may combine multiple inventors who share the name “JONCZYK ALFRED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
35 patentsUS6001961ADec 14, 1999
Cyclic adhesion inhibitors
MERCK PATENT GMBH88 citations94
US5849692ADec 15, 1998
Cyclic peptides containing Arg-Gly-Asp, and derivatives thereof, as adhesion inhibitors
MERCK PATENT GMBH44 citations93
US6280760B1Aug 28, 2001
Peptide-coated implants and methods for producing same
MERCK PATENT GMBH43 citations92
US5866540AFeb 2, 1999
Cyclic adhesion inhibitors
MERCK PATENT GMBH42 citations91
US5693612ADec 2, 1997
Cyclopeptides of the formula I
MERCK PATENT GMBH32 citations89
US5962638AOct 5, 1999
Peptides and synthetic cell membranes
MERCK PATENT GMBH21 citations86
US7470702B2Dec 30, 2008
Benzimidazoles
MERCK PATENT GMBH14 citations84
US7138417B2Nov 21, 2006
Inhibitors of integrin αvβ6
MERCK PATENT GMBH17 citations84
US6127335AOct 3, 2000
Cyclic adhesion inhibitors
MERCK PATENT GMBH18 citations83
US7547695B2Jun 16, 2009
Pyridopyrimidinones
MERCK PATENT GMBH11 citations80
US6683051B1Jan 27, 2004
Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
MERCK PATENT GMBH15 citations77
US4755592AJul 5, 1988
Statine-containing peptides useful in medicaments
MERCK PATENT GMBH11 citations73
US10179777B2Jan 15, 2019
3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives
MERCK PATENT GMBH2 citations72
US6534478B1Mar 18, 2003
Cyclic azapeptides with angiogenic effect
MERCK PATENT GMBH8 citations72
US6169072B1Jan 2, 2001
Cyclic adhesion inhibitors
MERCK PATENT GMBH8 citations72
US6822074B1Nov 23, 2004
Process for the preparation of cyclo(Asp-DPhe-NMeVal-Arg-Gly)
MERCK PATENT GMBH7 citations70
US6576637B1Jun 10, 2003
β-alanine derivatives
MERCK PATENT GMBH10 citations70
US9051307B2Jun 9, 2015
Bipyridyl derivatives
MERCK PATENT GMBH2 citations63
US8912216B2Dec 16, 2014
Hetaryl-[1,8]naphthyridine derivatives
MERCK PATENT GMBH2 citations63
US6645991B1Nov 11, 2003
αvβ3 integrin inhibitors
MERCK PATENT GMBH5 citations63
US8003657B2Aug 23, 2011
Heterocyclic substituted bisarylurea derivatives
MERCK PATENT GMBH4 citations62
US7846927B2Dec 7, 2010
N,N′-diphenylurea derivatives suitable as kinase inhibitors
MERCK PATENT GMBH2 citations62
US4709010ANov 24, 1987
Peptides useful for inhibition of renin
MERCK PATENT GMBH4 citations62
US4812555AMar 14, 1989
Peptides possessing renin inhibitory activity
MERCK PATENT GMBH6 citations61
US5747457AMay 5, 1998
Linear adhesion inhibitors
MERCK PATENT GMBH2 citations60
US6566491B2May 20, 2003
Cyclopeptide derivatives
MERCK PATENT GMBH3 citations57
US7632951B2Dec 15, 2009
Inhibitors of integrin ανβ6
MERCK PATENT GMBH1 citations52
US5215966AJun 1, 1993
Peptide and renin inhibitors
MERCK PATENT GMBH1 citations52
US7759302B2Jul 20, 2010
Peptidic sulfonamides
MERCK PATENT GMBH0 citations48
US8765684B2Jul 1, 2014
Solid materials of {[(2S,5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acetic acid} and methods for obtaining them
MERCK PATENT GMBH1 citations47
US9382244B2Jul 5, 2016
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours
MERCK PATENT GMBH1 citations46
US7135587B2Nov 14, 2006
Urea and urethane derivatives as integrin inhibitors
MERCK PATENT GMBH0 citations42
US7528139B2May 5, 2009
Sulfonamides
MERCK PATENT GMBH0 citations41
US10278911B2May 7, 2019
Compositions containing cyclic peptides and methods of use
MERCK PATENT GMBH0 citations39
US7745434B2Jun 29, 2010
4-Amino-5-oxo-8-phenyl-5H-pyrido(2,3-D) pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours
MERCK PATENT GMBH0 citations35
JONCZYK ALFRED
3 patentsDORSCH DIETER
2 patentsUS8791113B2Jul 29, 2014
2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
DORSCH DIETER17 citations84
US9051318B2Jun 9, 2015
Pyrido [2, 3-B] pyrazine compounds and their therapeutical uses such as for inhibiting ATP consuming proteins and treating diseases associated therewith
DORSCH DIETER6 citations73